To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No benefits to Cartipatch compared to mosaicplasty for osteochondral defects in the knee

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2016

No benefits to Cartipatch compared to mosaicplasty for osteochondral defects in the knee

Vol: 5| Issue: 7| Number:38| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Third-Generation Autologous Chondrocyte Implantation Versus Mosaicplasty for Knee Cartilage Injury: 2-Year Randomized Trial

J Orthop Res. 2016 Apr;34(4):658-65

Contributing Authors:
A Clavé JF Potel E Servien P Neyret F Dubrana E Stindel

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

55 patients with knee cartilage injuries were randomized to either undergo autologous chondrocyte implantation (ACI) with the use of the Cartipatch scaffold (solid agarose-alginate) or osteochondral transfer through mosaicplasty with an autograft. The purpose of this study was to compare clinical outcomes between ACI with the Cartipatch scaffold as assessed by subjective International Knee Documen...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.